- $16.61m
- $29.43m
- $37.06m
NASDAQ RESUMED AT 02:27 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:22 PM
NASDAQ RESUMED AT 02:17 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:12 PM
NASDAQ RESUMED AT 02:11 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
NASDAQ RESUMED AT 11:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:26 AM
Brief: Cytosorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Cytosorbents Corp reports results for the quarter ended June 30 - Earnings Summary
CytoSorbents Q2 adjusted loss narrows on cost controls
Cytosorbents Corp expected to post a loss of 4 cents a share - Earnings Preview
CytoSorbents Q1 revenue rises
CytoSorbents 2025 revenue rises, net loss narrows
CytoSorbents' prelim 2025 revenue misses estimates